openPR Logo
Press release

Investigation announced for Investors in Biohaven Ltd. (NYSE: BHVN) over potential Wrongdoing

An investigation on behalf of investors in Biohaven Ltd. (NYSE: BHVN) shares over potential wrongdoing at Biohaven Ltd.

An investigation on behalf of investors in Biohaven Ltd. (NYSE: BHVN) shares over potential wrongdoing at Biohaven Ltd.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Biohaven Ltd.

Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Biohaven Ltd. directors breached their fiduciary duties and caused damage to the company and its shareholders.

New Haven, CT based Biohaven Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States.

On July 27, 2023, Biohaven Ltd. announced, among other items, that "[o]n its SCA program, the FDA informed Biohaven that it would not review the recently submitted NDA application for troriluzole given that the study's primary endpoint was not met and thus, would not permit a substantive review."

Shares of Biohaven Ltd. (NYSE: BHVN) declined from $25.84 per share on June 14, 2023, to as low as $17.10 per share on July 27, 2023.

Those who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Biohaven Ltd. (NYSE: BHVN) over potential Wrongdoing here

News-ID: 3531405 • Views:

More Releases from Shareholders Foundation, Inc.

Neogen Corporation (NASDAQ: NEOG) Investor Alert: Deadline in Lawsuit on September 16, 2025
Neogen Corporation (NASDAQ: NEOG) Investor Alert: Deadline in Lawsuit on Septemb …
A deadline is coming up on September 16, 2025 in the lawsuit filed for certain investors of Neogen Corporation (NASDAQ: NEOG) over alleged securities laws violations by Neogen Corporation. Investors who purchased shares of Neogen Corporation (NASDAQ: NEOG) have certain options and there are strict and short deadlines running. Deadline: September 16, 2025. Neogen Corporation (NASDAQ: NEOG) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According
Lawsuit filed for Investors who lost money with shares of C3.ai, Inc. (NYSE: AI)
Lawsuit filed for Investors who lost money with shares of C3.ai, Inc. (NYSE: AI)
An investor, who purchased shares of C3.ai, Inc. (NYSE: AI), filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by C3.ai, Inc. Investors who purchased shares of C3.ai, Inc. (NYSE: AI) have certain options and for certain investors are short and strict deadlines running. Deadline: October 21, 2025. NYSE: AI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Reddit, Inc. (NYSE: RDDT) Long Term Investor Alert: Investigation of potential Wrongdoing
Reddit, Inc. (NYSE: RDDT) Long Term Investor Alert: Investigation of potential W …
An investigation on behalf of current long-term investors in shares of Reddit, Inc. (NYSE: RDDT) concerning potential breaches of fiduciary duties by certain directors and officers of Reddit, Inc. was announced. Investors who are current long term investors in Reddit, Inc. (NYSE: RDDT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Luminar Technologies, Inc. (NASDAQ: LAZR) Investor Alert: Deadline in Lawsuit on September 22, 2025
Luminar Technologies, Inc. (NASDAQ: LAZR) Investor Alert: Deadline in Lawsuit on …
A deadline is coming up on September 22, 2025 in the lawsuit filed for certain investors of Luminar Technologies, Inc. (NASDAQ: LAZR) over alleged securities laws violations by Luminar Technologies, Inc. Investors who purchased shares of Luminar Technologies, Inc. (NASDAQ: LAZR) have certain options and there are strict and short deadlines running. Deadline: September 22, 2025. Luminar Technologies, Inc. (NASDAQ: LAZR) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or

All 5 Releases


More Releases for Biohaven

Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd. Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Obsessive Compulsive Disorder Market Growth Projections 2024-2034: DelveInsight …
The Key Obsessive Compulsive Disorder Companies in the market include - Biohaven Pharmaceuticals, Inc., AbbVie, AstraZeneca, MedtronicNeuro, Hoffmann-La Roche, Ortho-McNeil Pharmaceutical, Forest Laboratories, Eli Lilly and Company, Janssen-Ortho Inc., Pfizer, and others. DelveInsight's "Obsessive Compulsive Disorder Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Obsessive Compulsive Disorder, historical and forecasted epidemiology as well as the Obsessive Compulsive Disorder market trends in the United States, EU4 (Germany,
Obsessive Compulsive Disorder Market to Show Remarkable Growth Trends from 2024 …
DelveInsight's "Obsessive Compulsive Disorder Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Obsessive Compulsive Disorder, historical and forecasted epidemiology as well as the Obsessive Compulsive Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the OCD market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Obsessive Compulsive Disorder Market Forecast [https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr] Some
Obsessive Compulsive Disorder Market Expected to Experience Major Growth by 2034 …
DelveInsight's "Obsessive Compulsive Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Obsessive Compulsive Disorder, historical and forecasted epidemiology as well as the Obsessive Compulsive Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the OCD market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Obsessive Compulsive Disorder Market Forecast https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some
Spinocerebellar Ataxias Market Value Strategic Analysis | Biohaven Pharmaceutica …
According to HTF Market Intelligence, the Spinocerebellar Ataxias market to witness a CAGR of xx% during the forecast period (2024-2030). The Latest published a market study on Global Spinocerebellar Ataxias Market provides an overview of the current market dynamics in the Global Spinocerebellar Ataxias space, as well as what our survey respondents- all outsourcing decision-makers- predict the market will look like in 2030. The study breaks the market by revenue
Obsessive Compulsive Disorder Market to Exhibit Rapid Growth Rate During the For …
DelveInsight's "Obsessive Compulsive Disorder Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Obsessive Compulsive Disorder, historical and forecasted epidemiology as well as the Obsessive Compulsive Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Obsessive Compulsive Disorder market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Obsessive Compulsive Disorder